Society AC. Cancer facts & figures. The Society; 2008.
Siddeek RAT, Gupta A, Gupta S, Goyal B, Gupta AK, Agrawal S, et al. Evaluation of platelet distribution width as novel biomarker in gall bladder cancer. J Carcinogenesis. 2020;19:5.
Control CfD. Prevention. Inside knowledge: Get the facts about gynecologic cancers. 2015;2014.
Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Borj MR, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021;161(1):314–27.
Goker A, Guvenal T, Yanikkerem E, Turhan A, Koyuncu F. Quality of life in women with gynecologic cancer in Turkey. Asian Pac J Cancer Prev. 2011;12(11):3121–8.
Terzioğlu F, Alan H. The effect of some psychological problems experienced during gynecological cancer treatment upon women’s sexual life. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2015;18(2):140–7.
Tetteh DA. “I feel different”: ovarian cancer and sexual self-concept. Women’s Reproductive Health. 2017;4(1):61–73.
CDC. Gynecologic cancers. 2017. www.cdc.gov/cancer/gynecologic/.
Pieterse Q, Maas C, Ter Kuile M, Lowik M, Van Eijkeren M, Trimbos J, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16(3):1119–29.
Cleary V, Hegarty J, McCarthy G, Eds. Sexuality in Irish women with gynecologic cancer. Oncol Nurs Forum. 2011;38:87–96.
Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function: a longitudinal study. Cancer. 2004;100(1):97–106.
Oskay ÜY, Beji NK, Bal MD, Yılmaz SD. Evaluation of sexual function in patients with gynecologic cancer and evidence-based nursing interventions. Sex Disabil. 2011;29(1):33–41.
Reis N, Beji NK, Coskun A. Quality of life and sexual functioning in gynecological cancer patients: results from quantitative and qualitative data. Eur J Oncol Nurs. 2010;14(2):137–46.
Bal MD, Yilmaz SD, Beji NK. Sexual health in patients with gynecological cancer: a qualitative study. Sex Disabil. 2013;31(1):83–92.
Cleary V, Hegarty J. Understanding sexuality in women with gynaecological cancer. Eur J Oncol Nurs. 2011;15(1):38–45.
Cory L, Morgan MA. Pathology consultation for the gynecologic oncologist: what the surgeon wants to know. Arch Pathol Lab Med. 2018;142(12):1503–8.
SIegel RL, et al. Cancer statistics. CA Cancer J Clin. 2018;68:7–30.
Cokkinides V, Albano J, Samuels A, Ward M, Thum J. American cancer society: cancer facts and figures. Atlanta: American Cancer Society; 2005.
Colon SJ. Human papillomavirus and cervical cancer. 2018.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Keyvani V, Farshchian M, Esmaeili S-A, Yari H, Moghbeli M, Nezhad S-RK, et al. Ovarian cancer stem cells and targeted therapy. J Ovarian Res. 2019;12(1):1–11.
Institute NC. Cancer stat facts: ovarian cancer. 2018.
Abbaszadegan MR, Taghehchian N, Aarabi A, Akbari F, Saburi E, Moghbeli M. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma. Diagn Pathol. 2021;16(1):36. https://doi.org/10.1186/s13000-021-01098-z.
Abbaszadegan MR, Taghehchian N, Aarabi A, Moghbeli M. MAEL Cancer-testis antigen as a diagnostic marker in primary stages of gastric cancer with helicobacter pylori infection. J Gastrointest Cancer. 2020;51(1):17–22. https://doi.org/10.1007/s12029-018-0183-3.
Forghanifard MM, Naeimi Khorasanizadeh P, Abbaszadegan MR, Javdani Mallak A, Moghbeli M. Role of DIDO1 in progression of esophageal squamous cell carcinoma. J Gastrointest Cancer. 2020;51(1):83–7. https://doi.org/10.1007/s12029-019-00212-1.
Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018;29(1):e7. https://doi.org/10.3802/jgo.2018.29.e7.
Health NIo. National cancer institute: surveillance, epidemiology, and end results program. Cancer Stat Facts: Uterine Cancer. 2019.
Yang T, Cairns BJ, Allen N, Sweetland S, Reeves GK, Beral V. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer. 2012;107(1):169–75.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. 2017.
Ledford LR, Lockwood S. Scope and epidemiology of gynecologic cancers: an overview. Semin Oncol Nurs. 2019;35:147–50.
Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019;18(1):29–37.
Harper EI, Sheedy EF, Stack MS. With great age comes great metastatic ability: ovarian cancer and the appeal of the aging peritoneal microenvironment. Cancers. 2018;10(7):230.
Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol. 2005;193(5):1640–4.
Strander B, Hällgren J, Sparén P. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. BMJ. 2014;348:f7361.
El Ibrahimi S, Pinheiro PS. The effect of marriage on stage at diagnosis and survival in women with cervical cancer. Psychooncology. 2017;26(5):704–10.
Alterman T, Burnett C, Peipins L, Lalich N, Halperin W. Occupation and cervical cancer: an opportunity for prevention. J Womens Health. 1997;6(6):649–57.
Le ND, Leung A, Brooks-Wilson A, Gallagher RP, Swenerton KD, Demers PA, et al. Occupational exposure and ovarian cancer risk. Cancer Causes Control. 2014;25(7):829–41.
Shao Z, Zhu T, Zhang P, Wen Q, Li D, Wang S. Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer. Health Qual Life Outcomes. 2017;15(1):144.
Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004;94(12):2104–11.
Derakhshan A, Manshaei G, Afshar H, Goli F. Effect of a bioenergy economy program on pain control, depression, and anxiety in patients with migraine headache. Int J Body Mind Culture. 2016:30–45.
Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Scalisi A, Agodi A. The association of dietary patterns with high-risk human papillomavirus infection and cervical cancer: a cross-sectional study in Italy. Nutrients. 2018;10(4):469.
Campbell CL, Campbell LC. A systematic review of cognitive behavioral interventions in advanced cancer. Patient Educ Couns. 2012;89(1):15–24.
Yazdanpanah E, Mahmoudi M, Sahebari M, Rezaieyazdi Z, Esmaeili SA, Tabasi N, et al. Vitamin D3 alters the expression of toll-like receptors in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. J Cell Biochem. 2017;118(12):4831–5.
García-Closas R, Castellsagué X, Bosch X, González CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 2005;117(4):629–37.
Ocalewski J, Michalska P, Izdebski P, Jankowski M, Zegarski W. Fear of cancer progression and health behaviors in patients with colorectal cancer. Am J Health Behav. 2021;45(1):138–51.
McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr. 2003;133(6):1937–42.
Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Prev Biomarkers. 2014;23(2):255–73.
Sturgeon SR, Ziegler RG, Brinton LA, Nasca PC, Mallin K, Gridley G. Diet and the risk of vulvar cancer. Ann Epidemiol. 1991;1(5):427–37.
Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011;55(6):931–40.
Zhou Y, Chlebowski R, LaMonte MJ, Bea JW, Qi L, Wallace R, et al. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women’s Health Initiative. Gynecol Oncol. 2014;133(1):4–10.
Zamorano AS, Hagemann AR, Morrison L, Lee JA, Liao LM, Brinton LA, et al. Pre-diagnosis body mass index, physical activity and ovarian cancer mortality. Gynecol Oncol. 2019;155(1):105–11.
Park S, Kim K, Ahn HK, Kim JW, Min G, Chung BH, et al. Impact of lifestyle intervention for patients with prostate cancer. Am J Health Behav. 2020;44(1):90–9.
Conroy MB, Sattelmair JR, Cook NR, Manson JE, Buring JE, Lee I-M. Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control. 2009;20(7):1107–15.
Seo S-S, Oh HY, Kim MK, Lee DO, Chung YK, Kim J-Y, et al. Combined effect of secondhand smoking and alcohol drinking on risk of persistent human papillomavirus infection. BioMed Res Int. 2019;2019:1–9.
Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer. 2008;112(5):1169–77.
Je Y, DeVivo I, Giovannucci E. Long-term alcohol intake and risk of endometrial cancer in the nurses’ health study, 1980–2010. Br J Cancer. 2014;111(1):186–94.
Gosvig CF, Kjaer SK, Blaakær J, Høgdall E, Høgdall C, Jensen A. Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: results from a Danish case-control study. Acta Oncol. 2015;54(8):1144–51.
Je Y, Hankinson SE, Tworoger SS, DeVivo I, Giovannucci E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemio Prev Biomarkers. 2011;20(12):2487–95.
Chiou W-Y, Chen C-A, Lee M-S, Lin H-Y, Li C-Y, Su Y-C, et al. Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone. Medicine. 2016;95(47):e5409.
Parizi PK, Yarahmadi F, Tabar HM, Hosseini Z, Sarli A, Kia N, et al. MicroRNAs and target molecules in bladder cancer. Med Oncol. 2020;37(12):1–33.
Lin H-W, Wang P-H, Lee C-Y, Huang J-Y, Yang S-F, Hsiao Y-H. The Risk of gynecologic and urinary tract cancer with pelvic inflammatory disease: a population-based cohort study. J Cancer. 2019;10(1):28.
Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstet Gynecol. 2011;2011:1–6.
Liu R, Tang S, Feng F, Liu C, Wang L, Zhao W, et al. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. Arch Gynecol Obstet. 2019;299(1):35–46.
Walker JL, Manetta A, Mannel RS, Berman ML, DiSaia PJ. The influence of endometriosis on the staging of cervical cancer. Obstet Gynecol. 1990;75(3 Pt 2):543–5.
Burghaus S, Häberle L, Schrauder MG, Heusinger K, Thiel FC, Hein A, et al. Endometriosis as a risk factor for ovarian or endometrial cancer—results of a hospital-based case–control study. BMC Cancer. 2015;15(1):751.
留言 (0)